Cargando…

Editorial: Pharmacogenomics of Adverse Drug Reactions

Detalles Bibliográficos
Autores principales:	Siddiqui, Moneeza K., Luzum, Jasmine, Coenen, Marieke, Mahmoudpour, Seyed Hamidreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940279/ https://www.ncbi.nlm.nih.gov/pubmed/35330732 http://dx.doi.org/10.3389/fgene.2022.859909

Ejemplares similares

The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review
por: Baye, Assefa M., et al.
Publicado: (2021)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Pharmacogenomics of COVID-19 therapies
por: Takahashi, Takuto, et al.
Publicado: (2020)

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022)

Focus on pharmacogenomics, phytonutrient–drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2022)

Focus on pharmacogenomics, phytonutrient-drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2021)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Editorial: The role of pharmacogenomics in addressing health disparities: the path, the promise, and the barriers
por: Roman, Youssef M.
Publicado: (2023)

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam
por: Campbell, Ciarán, et al.
Publicado: (2022)

The Apportionment of Pharmacogenomic Variation: Race, Ethnicity, and Adverse Drug Reactions
por: Jordan, I. King, et al.
Publicado: (2022)

Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions
por: Tong, Hang, et al.
Publicado: (2021)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021)

Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2021)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
por: Miltyk, Wojciech, et al.
Publicado: (2022)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
por: King, Charlotte, et al.
Publicado: (2020)

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2015)

Pharmacogenomics and health disparities, are we helping?
por: Shaaban, Sherin, et al.
Publicado: (2023)

Adverse Drug Reaction Discovery Using a Tumor-Biomarker Knowledge Graph
por: Wang, Meng, et al.
Publicado: (2021)

Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization
por: King, Charlotte, et al.
Publicado: (2020)

Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014)

Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
por: Tafazoli, Alireza, et al.
Publicado: (2023)

Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019)

Editorial: The Immunology of Adverse Drug Reactions
por: Illing, Patricia T., et al.
Publicado: (2022)

A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics
por: Brown, Chad, et al.
Publicado: (2011)

Addressing disparities in pharmacogenomics through rural and underserved workforce education
por: Brown, Jacob T., et al.
Publicado: (2023)

Calculation of the pharmacogenomics benefit score for patients with medication-related problems
por: Polasek, Thomas M.
Publicado: (2023)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
por: Abdelhalim, Habiba, et al.
Publicado: (2022)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
por: Simona, Aurélien, et al.
Publicado: (2023)

Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy
por: Soto-Pedre, Enrique, et al.
Publicado: (2021)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
por: Wang, Chuang-Wei, et al.
Publicado: (2022)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
por: Tempark, Therdpong, et al.
Publicado: (2022)

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
por: Alessandrini, Marco, et al.
Publicado: (2016)

Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
por: Just, Katja S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_odqa1mfdrakj2n12m37n9mi2tq